APOE genotype and neuroimaging markers of Alzheimer's disease: Systematic review and meta-analysis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 2, 2015, Pages 127-134

  Liu, Ying ^a   Yu, Jin Tai ^a,b,c   Wang, Hui Fu ^c   Han, Pei Ran ^a   Tan, Chen Chen ^b   Wang, Chong ^b   Meng, Xiang Fei ^b   Risacher, Shannon L ^d   Saykin, Andrew J ^d   Tan, Lan ^a,b,c  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; APOLIPOPROTEIN E; GLUCOSE; AMYLOID; APOLIPOPROTEIN E4; BIOLOGICAL MARKER;

ALLELE; ALZHEIMER DISEASE; AMYLOID PLAQUE; APOE GENE; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; BRAIN SIZE; CELL LOSS; DISEASE ASSOCIATION; GENE FUNCTION; GENETIC ASSOCIATION; GENOTYPE; HIPPOCAMPAL VOLUME; HUMAN; METABOLIC RATE; MIDDLE FRONTAL GYRUS; NERVE CELL; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEIN METABOLISM; SYSTEMATIC REVIEW; ATROPHY; BRAIN CORTEX; GENETICS; HIPPOCAMPUS; META ANALYSIS; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID; APOLIPOPROTEIN E4; ATROPHY; BIOMARKERS; CEREBRAL CORTEX; GENOTYPE; GLUCOSE; HIPPOCAMPUS; HUMANS; NEUROIMAGING;

EID: 84921411688     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-307719     Document Type: Article

References (40)

1. Petersen RC, Jack CR Jr, Xu YC, et al. Memory and MRI-based hippocampal volumes in aging and AD. Neurology 2000;54:581-7.
2. Shi F, Liu B, Zhou Y, et al. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: meta-analyses of MRI studies. Hippocampus 2009;19:1055-64.
3. Geroldi C, Laakso MP, DeCarli C, et al. Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry 2000;68:93-6.
4. Reiman EM, Uecker A, Caselli RJ, et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 1998;44:288-91.
5. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-19.
6. Hashimoto M, Yasuda M, Tanimukai S, et al. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 2001;57:1461-6.
7. Radua J, Mataix-Cols D, Phillips ML, et al. A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. Eur Psychiatry 2012;27:605-11.
8. Risacher SL, Kim S, Shen L, et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci 2013;5:11.
9. Song F, Sheldon TA, Sutton AJ, et al. Methods for exploring heterogeneity in meta-analysis. Eval Health Prof 2001;24:126-51.
10. Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ 1997;315:1533-7.
11. Bora E, Fornito A, Radua J, et al. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res 2011;127:46-57.
12. Hart H, Radua J, Mataix-Cols D, et al. Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD). Neurosci Biobehav Rev 2012;36:2248-56.
13. Jacobs HI, Radua J, Luckmann HC, et al. Meta-analysis of functional network alterations in Alzheimer's disease: toward a network biomarker. Neurosci Biobehav Rev 2013;37:753-65.
14. Shi J, Lepore N, Gutman BA, et al. Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: an N=725 surface-based Alzheimer's disease neuroimaging initiative study. Hum Brain Mapp 2014. doi:10.1002/hbm.22447
15. Mori E, Lee K, Yasuda M, et al. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. Ann Neurol 2002;51:209-14.
16. Pievani M, Galluzzi S, Thompson PM, et al. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease. NeuroImage 2011;55:909-19.
17. Protas HD, Chen K, Langbaum JB, et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol 2013;70:320-5.
18. Rowe CC, Ellis KA, Rimajova M, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 2010;31:1275-83.
19. Fleisher AS, Chen K, Liu X, et al. Apolipoprotein E epsilon4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging 2013;34:1-12.
20. Ossenkoppele R, van der Flier WM, Zwan MD, et al. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology 2013;80:359-65.
21. Yi D, Lee DY, Sohn BK, et al. Beta-Amyloid Associated Differential Effects of APOE epsilon4 on Brain Metabolism in Cognitively Normal Elderly. Am J Geriatr Psychiatry 2014. doi:10.1016/j.jagp.2013.12.173
22. Jagust WJ, Landau SM. Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging. J Neurosci 2012;32:18227-33.
23. Langbaum JB, Chen K, Caselli RJ, et al. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele. Arch Neurol 2010;67:462-8.
24. Reiman EM, Chen K, Alexander GE, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci 2003;101:284-89.
25. Mosconi L, Sorbi S, Nacmias B, et al. Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study. Psychiatry Res 2004;130:141-51.
26. Drzezga A, Grimmer T, Henriksen G, et al. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology 2009;72:1487-94.
27. Grimmer T, Tholen S, Yousefi BH, et al. Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimer's disease. Biol Psychiatry 2010;68:879-84.
28. Allen SJ, MacGowan SH, Tyler S, et al. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. Neurosci Lett 1997;239:33-6.
29. Berg L, McKeel DW Jr, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 1998; 55:326-35.
30. Deane R, Sagare A, Hamm K, et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 2008;118:4002-13.
31. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30.
32. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
33. Ye S, Huang Y, Mullendorff K, et al. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc Natl Acad Sci USA 2005;102:18700-5.
34. Morra JH, Tu Z, Apostolova LG, et al. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. NeuroImage 2009;45:S3-15.
35. Mueller SG, Weiner MW. Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields. Hippocampus 2009;19:558-64.
36. Naslund J, Thyberg J, Tjernberg LO, et al. Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron 1995;15:219-28.
37. Rebeck GW, Reiter JS, Strickland DK, et al. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11:575-80.
38. Ashford JW. APOE genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci 2004;23:157-65.
39. Greicius MD, Srivastava G, Reiss AL, et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004;101:4637-42.
40. Mormino EC, Smiljic A, Hayenga AO, et al. Relationships between beta-amyloid and functional connectivity in different components of the default mode network in aging. Cereb Cortex 2011;21:2399-407.